Institution
Seattle Children's
Healthcare•
About: Seattle Children's is a based out in . It is known for research contribution in the topics: Population & Medicine. The organization has 2774 authors who have published 5131 publications receiving 134945 citations. The organization is also known as: Children's Hospital and Regional Medical Center & Seattle Children's Hospital.
Topics: Population, Medicine, Transplantation, Health care, Poison control
Papers published on a yearly basis
Papers
More filters
Gregory A. Roth1, Gregory A. Roth2, Degu Abate3, Kalkidan Hassen Abate4 +1025 more•Institutions (333)
TL;DR: Non-communicable diseases comprised the greatest fraction of deaths, contributing to 73·4% (95% uncertainty interval [UI] 72·5–74·1) of total deaths in 2017, while communicable, maternal, neonatal, and nutritional causes accounted for 18·6% (17·9–19·6), and injuries 8·0% (7·7–8·2).
5,211 citations
Jeffrey D. Stanaway1, Ashkan Afshin1, Emmanuela Gakidou1, Stephen S Lim1 +1050 more•Institutions (346)
TL;DR: This study estimated levels and trends in exposure, attributable deaths, and attributable disability-adjusted life-years (DALYs) by age group, sex, year, and location for 84 behavioural, environmental and occupational, and metabolic risks or groups of risks from 1990 to 2017 and explored the relationship between development and risk exposure.
2,910 citations
University of Pittsburgh1, Institute for Health Metrics and Evaluation2, University of Washington3, University of British Columbia4, The George Institute for Global Health5, Federal University of São Paulo6, Charité7, University of London8, Seattle Children's9, University of São Paulo10, University of Melbourne11
TL;DR: Despite declining age-standardised incidence and mortality, sepsis remains a major cause of health loss worldwide and has an especially high health-related burden in sub-Saharan Africa.
2,419 citations
Seattle Children's1, Case Western Reserve University2, University of Maryland, Baltimore3, University of Missouri–Kansas City4, Indiana University5, University of Colorado Denver6, Boston Children's Hospital7, University of British Columbia8, Thomas Jefferson University9, American Academy of Pediatrics10, Alfred I. duPont Hospital for Children11, Morehouse College12, Harvard University13, University of Texas Health Science Center at Houston14, University of Pittsburgh15, Columbia University Medical Center16, Cincinnati Children's Hospital Medical Center17
TL;DR: These pediatric hypertension guidelines are an update to the 2004 report and include revised recommendations on when to perform echocardiography in the evaluation of newly diagnosed hypertensive pediatric patients (generally only before medication initiation), along with a revised definition of left ventricular hypertrophy.
Abstract: These pediatric hypertension guidelines are an update to the 2004 “Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents.” Significant changes in these guidelines include (1) the replacement of the term “prehypertension” with the term “elevated blood pressure,” (2) new normative pediatric blood pressure (BP) tables based on normal-weight children, (3) a simplified screening table for identifying BPs needing further evaluation, (4) a simplified BP classification in adolescents ≥13 years of age that aligns with the forthcoming American Heart Association and American College of Cardiology adult BP guidelines, (5) a more limited recommendation to perform screening BP measurements only at preventive care visits, (6) streamlined recommendations on the initial evaluation and management of abnormal BPs, (7) an expanded role for ambulatory BP monitoring in the diagnosis and management of pediatric hypertension, and (8) revised recommendations on when to perform echocardiography in the evaluation of newly diagnosed hypertensive pediatric patients (generally only before medication initiation), along with a revised definition of left ventricular hypertrophy. These guidelines include 30 Key Action Statements and 27 additional recommendations derived from a comprehensive review of almost 15 000 published articles between January 2004 and July 2016. Each Key Action Statement includes level of evidence, benefit-harm relationship, and strength of recommendation. This clinical practice guideline, endorsed by the American Heart Association, is intended to foster a patient- and family-centered approach to care, reduce unnecessary and costly medical interventions, improve patient diagnoses and outcomes, support implementation, and provide direction for future research.
2,082 citations
TL;DR: A novel system to grade the severity of CRS in individual patients and a treatment algorithm for management of C RS based on severity is presented, to maximize the chance for therapeutic benefit from the immunotherapy while minimizing the risk for life threatening complications of the syndrome.
2,025 citations
Authors
Showing all 2790 results
| Name | H-index | Papers | Citations |
|---|---|---|---|
| Christopher J L Murray | 209 | 754 | 310329 |
| Lawrence Corey | 146 | 773 | 78105 |
| Frederick P. Rivara | 118 | 940 | 86352 |
| William B. Dobyns | 105 | 430 | 38956 |
| Hans D. Ochs | 102 | 419 | 39881 |
| Amy S. Lee | 100 | 487 | 35019 |
| Jean E. Sanders | 99 | 328 | 35114 |
| Elaine H. Zackai | 99 | 645 | 38723 |
| Wendy M. Leisenring | 93 | 499 | 36149 |
| Irwin D. Bernstein | 89 | 311 | 26624 |
| Michael J. Bamshad | 86 | 334 | 35118 |
| Brian E. Saelens | 85 | 281 | 35223 |
| Janet A. Englund | 80 | 360 | 20298 |
| Dimitri A. Christakis | 79 | 284 | 20590 |
| Donna M. McDonald-McGinn | 74 | 317 | 21359 |